Assessment of myocardial viability with 3D MRI at 3 T

American Journal of Roentgenology

Volumn 192, Issue 6, 2009, Pages 1645-1650

  Bauner, Kerstin U ^a   Muehling, Olaf ^a   Theisen, Daniel ^a   Hayes, Carmel ^b   Wintersperger, Bernd J ^a   Reiser, Maximilian F ^a   Huber, Armin M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Cardiovascular MRI   (Germany)

Author keywords

3 T; 3D imaging; Cardiac imaging; MRI; Viability

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67049110251     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1394     Document Type: Article

References (34)

1. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96:793-800 (Pubitemid 27329611)
2. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983; 67: 766-778
3. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992-2002 (Pubitemid 29529292)
4. Kühl HP, Papavasiliu TS, Beek AM, Hofman MB, Heusen NS, van Rossum AC. Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion- recovery prepared pulse sequence. Radiology 2004; 230:576-582 (Pubitemid 38133825)
5. Kim RJ, Wu E, Rafael A, et al. The use of contrast- enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453 (Pubitemid 30832880)
6. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215-223 (Pubitemid 32151298)
7. Bauner KU, Muehling O, Wintersperger BJ, Winnik E, Reiser MF, Huber A. Inversion recovery single-shot TurboFLASH for assessment of myocardial infarction at 3 Tesla. Invest Radiol 2007; 42:361-371 (Pubitemid 46788734)
8. Li W, Li BS, Polzin JA, Mai VM, Prasad PV, Edelman RR. Myocardial delayed enhancement imaging using inversion recovery single-shot steady-state free precession: initial experience. J Magn Reson Imaging 2004; 20:327-330 (Pubitemid 38970944)
9. Kellman P, Larson AC, Hsu LY, et al. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 2005; 53:194-200 (Pubitemid 40110492)
10. Foo TK, Stanley DW, Castillo E, et al. Myocardial viability: breath-hold 3D MR imaging of delayed hyperenhancement with variable sampling in time. Radiology 2004; 230:845-851 (Pubitemid 38252886)
11. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36:1985-1991 (Pubitemid 30844116)
12. Cochet A, Lalande A, Walker PM, et al. Comparison of the extent of delayed-enhancement cardiac magnetic resonance imaging with and without phase-sensitive reconstruction at 3.0 T. Invest Radiol 2007; 42:372-376 (Pubitemid 46788735)
13. Huber A, Bauner K, Wintersperger BJ, et al. Phase-sensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 Tesla. Invest Radiol 2006; 41:148-153 (Pubitemid 44406212)
14. Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology 2004; 233:921-926
15. Huber A, Schoenberg SO, Spannagl B, et al. Single- shot inversion recovery TrueFISP for assessment of myocardial infarction. AJR 2006; 186: 627-633 (Pubitemid 46100248)
16. Huber AM, Schoenberg SO, Hayes C, et al. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction. Radiology 2005; 237:854-860 (Pubitemid 41636372)
17. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002; 18:539-542 (Pubitemid 34262671)
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310 (Pubitemid 16134762)
19. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003; 108:1945-1953 (Pubitemid 37296539)
20. Depre C, Vanoverschelde JL, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995; 268: H1265-H1275
21. Dewey M, Kaufels N, Laule M, et al. Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium. Magn Reson Med 2004; 51:703-709 (Pubitemid 38420446)
22. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol 2006; 41:661-667 (Pubitemid 44213742)
23. Cheng AS, Robson MD, Neubauer S, Selvanayagam JB. Irreversible myocardial injury: assessment with cardiovascular delayed-enhancement MR imaging and comparison of 1.5 and 3.0 T-initial experience. Radiology 2007; 242:735-742 (Pubitemid 46310085)
24. Gutberlet M, Noeske R, Schwinge K, Freyhardt P, Felix R, Niendorf T. Comprehensive cardiac magnetic resonance imaging at 3.0 Tesla: feasibility and implications for clinical applications. Invest Radiol 2006; 41:154-167 (Pubitemid 44406213)
25. Disler DG, McCauley TR, Wirth CR, Fuchs MD. Detection of knee hyaline cartilage defects using fat-suppressed three-dimensional spoiled gradient- echo MR imaging: comparison with standard MR imaging and correlation with arthroscopy. AJR 1995; 165:377-382
26. Ross JS. MR imaging of the cervical spine: techniques for two- and three-dimensional imaging. AJR 1992; 159:779-786
27. Yagi A, Sato N, Taketomi A, et al. Normal cranial nerves in the cavernous sinuses: contrast-enhanced three-dimensional constructive interference in the steady state MR imaging. Am J Neuroradiol 2005; 26:946-950 (Pubitemid 43079797)
28. Dewey M, Laule M, Taupitz M, Kaufels N, Hamm B, Kivelitz D. Myocardial viability: assessment with three-dimensional MR imaging in pigs and patients. Radiology 2006; 239:703-709 (Pubitemid 43830605)
29. Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 2007; 26:375-385 (Pubitemid 47257737)
30. Fenchel M, Scheule AM, Stauder NI, et al. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology-initial clinical results. Radiology 2006; 238:280-291 (Pubitemid 43010606)
31. Wintersperger BJ, Reeder SB, Nikolaou K, et al. Cardiac CINE MR imaging with a 32-channel cardiac coil and parallel imaging: impact of acceleration factors on image quality and volumetric accuracy. J Magn Reson Imaging 2006; 23:222-227 (Pubitemid 43191078)
32. Stehning C, Boernert P, Nehrke K. Advances in coronary MRA from vessel wall to whole heart imaging. Magn Reson Med Sci 2007; 6:157-170
33. Peukert D, Kaufels N, Laule M, et al. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model. Invest Radiol 2007; 42:248-255 (Pubitemid 46398864)
34. Kelle S, Thouet T, Tangcharoen T, et al. Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset). Med Sci Monit 2007; 13:CR469-CR474 (Pubitemid 350106392)